Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parasite Clearance Time with Artemether/Lumefantrine in Malaria
NCT01998295Phase 4Completed
- Sponsor
- Muhimbili University of Health and Allied Sciences
- Start
- May 2012
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artemether + lumefantrine in Plasmodium falciparum malaria, sponsored by Muhimbili University of Health and Allied Sciences. Started May 2012; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT01998295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01998295.